U.K. patient cases from the global single-arm, open-label, multicentre STEVIE study of the hedgehog pathway inhibitor vismodegib in patients with advanced basal cell carcinoma : O01
Hard domestic water increases the risk of developing infantile eczema by 3 months of life : O02
The atypical chemokine-scavenging receptor ACKR2 prevents psoriasiform pathology by defining the boundaries of T-cell localization within the skin : O03
Acute stress and cutaneous mast cell function : O04
Incidence and management of skin-related adverse events associated with vemurafenib in BRAF V600E-positive metastatic melanoma: a 3-year retrospective cohort study of 107 patients : O05
The 10-year clinical outcomes of reduced-intensity allogeneic stem cell transplantation for patients with advanced-stage mycosis fungoides and Sézary syndrome : O06
Predicting factors influencing facial atrophic scarring in acne : O07
Ambient and sunbed ultraviolet radiation exposure: exposure rates, protection habits and attitudes of Irish teenagers aged 14-18 years before introduction of national sunbed legislation : O08
Utility of a clinical diagnostic matrix for characterizing epidermolysis bullosa in resource-limited settings : O09
Transplantation of autologous noncultured epidermal cell suspension in combination with platelet-rich plasma as a novel method in vitiligo surgery : O10
Biochip immunofluorescence microscopy as a new diagnostic tool for autoimmune blistering skin diseases : O11
ENLIST 1: a cross-sectional international multicentre prospective study of the clinical features of erythema nodosum leprosum : O12
Peristomal pyoderma gangrenosum: clinical features and therapy from a single-centre experience of 92 patients over 16 years : O13
Morphoea occurring on a background of systemic sclerosis: defining the relationship : O14
Methotrexate polyglutamates are associated with response to treatment in psoriasis: a prospective, multicentre, cohort study : O15
Identifying translational dermatology research priorities in the U.K.: results of an e-Delphi exercise : RF01
Differential persistence of four biological therapies for the treatment of moderate-to-severe psoriasis: a prospective observational cohort study from the British Association of Dermatologists' Biologic Interventions Register : RF02
A comprehensive omics assessment of etanercept therapy for psoriasis : RF03
An observer-blinded randomized controlled pilot study comparing localised psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of hand eczema : RF04
A case of toxic epidermal necrolysis-like cutaneous lupus erythematosus : CPC01
An asymptomatic bullous eruption arising from an old scar : CPC02
A diagnostic conundrum: dermatitis or something more? : CPC03
A giant congenital blue naevus with disseminated lesions : CPC04
Melanoma mimic in epidermolysis bullosa simplex : CPC05
Transient heliotrope eyelids: atypical, incomplete, adult-onset Still disease? : CPC06
Cutaneous malakoplakia in a nonhealing surgical wound : CPC07
Two case reports of generalized pustular psoriasis of pregnancy: different outcomes : CPC08
Clustered tender cheek nodules: a case of hereditary leiomyomatosis and renal cell cancer syndrome : CPC09
Carcinoma telangiectoides or haemorrhagiectoides: two cases demonstrating rare presentations of cutaneous metastases : CPC10
A case of cutaneous kaposiform lymphangiomatosis with chronic haemoptysis : CPC11
Infliximab-associated psoriasiform alopecia : CPC12
Lichenoid sarcoidosis: the great masquerader : CPC13
Necrobiotic xanthogranuloma treated with lenalidomide : CPC14
Two cases of nonuraemic calciphylaxis associated with warfarin therapy : CPC15
Subungual squamous cell carcinoma masquerading as onycholysis : P01
Cutaneous involvement as a late manifestation of adult-onset Langerhans cell histiocytosis : P02
Warfarin-induced skin necrosis and calciphylaxis: a diagnostic challenge : P03
Metastatic Crohn disease in the setting of multiple sclerosis : P04
Lichenoid pseudovesicular papular eruption on the nose: a new entity or a new variant of an existing dermatosis? : P05
Proton pump inhibitor-induced and -exacerbated subacute cutaneous lupus erythematosus : P06
TB or not TB? That is the question: a case of unilateral leg ulceration in an immunocompetent man : P07
Postirradiation morphoea and interstitial granuloma annulare : P08
Actinic granulomas in a patient with poorly controlled diabetes : P09
An unusual and potentially fatal cause of scalp crusting : P10
Palisaded neutrophilic granulomatous dermatitis: a recognizable clinical pattern in five patients : P11
Basal cell carcinoma and skin breast metastasis: a unique collision tumour : P12
Painful leg ulcers : P13
Calciphylaxis: more common than we think? : P14
Paradoxical exacerbation of chronic plaque psoriasis by sorafenib : P15
Blastic plasmacytoid dendritic cell neoplasm : P16
Poliosis secondary to halo naevi on the scalp : P17
A case report of giant melanoma: a rare clinical variant of cutaneous malignant melanoma : P18
Urticarial vasculitis following commencement of etanercept for psoriasis : P19
An assessment and comparison of pharmacists' and dermatologists' knowledge about the safety and efficacy of topical corticosteroids in paediatric atopic dermatitis: a source of topical corticosteroid phobia : P20 (PP6)
Educational video for patients undergoing Mohs micrographic surgery: a randomized controlled trial : P21 (PP7)
Evaluating the management of patients with psoriasis with biological therapies during standard U.K. clinical care (2001-2014), using National Institute for Health and Care Excellence guidance as a benchmark (PICTURE study) : P22
Allergic contact dermatitis in children: trends in allergens, 10 years on. A retrospective study of 500 children tested between 2005 and 2014 in one U.K. centre : P23 (PP11)
Efficacy of extracorporeal photopheresis in chronic cutaneous graft-versus-host disease: a retrospective study : P24 (PP8)
Are there sufficient numbers of low-risk basal cell carcinomas to justify primary care surgery services? : P25
Management of melanocytic tumour of uncertain malignant potential over 5 years (2009-2014) : P26
The impact of SIGN 140: audit of high-risk SCC using a year's data in three health boards : P27
Dermatological content of U.K. undergraduate curricula: where are we now? : P28
Experience of a regional dermatology teaching programme: a step to improving undergraduate dermatology teaching in the U.K. : P29
‘Wash-out’ period for oral tetracycline antibiotics prior to systemic isotretinoin : P30
Stripping down to the bare facts: the importance of full-skin examination in the diagnosis of malignant melanoma : P31
The spectrum of skin diseases in a multiethnic population in an urban setting in the U.K. : P32
Melanoma Diagnostic Index: comparative data to determine diagnostic sensitivity : P33
A regional audit of the management of onychomycosis in secondary care : P34
Virtual dermatology clinics introduced in a teaching hospital: a service evaluation audit of a new service : P35
Acute inpatient dermatology: is a dermatologist really necessary? : P36
Acne reaudit with emphasis on primary care referral patterns : P37
What's app in dermatology? : P38
Effectiveness and safety profile of prescribed double-dose antibiotics : P39
A review of dermatology primary care referral letters : P40
The use of the British Association of Dermatologists' app in a clinical setting: a student's perspective : P41
Safety of topical retinoids in women of childbearing age : P42
Differential neural response in patients with psoriasis: a functional magnetic resonance imaging study : P43 (PP1)
Loss of work productivity and quality of life in patients with autoimmune bullous dermatoses : P44
P45
Ebola: diagnosis and dermatology : P46 (PP10)
A systematic review of the natural history of recessive dystrophic epidermolysis bullosa : P47
Penoscrotodynia is a somatoform disorder and requires psychiatric treatment : P48
Insulin resistance and indices of insulin sensitivity in patients with hidradenitis suppurativa : P49
Antitumour necrosis factor agents and lupus-like syndromes: a critically appraised topic : P50
Uncommon presentation of Hansen disease: a case series : P51
Framingham risk, Q-risk and cardiovascular risk factors in hidradenitis suppurativa: a case-control study : P52
Barriers to cardiorespiratory fitness in patients with chronic plaque psoriasis : P53
A novel method of real-time quantification of skin-scale density demonstrating the effect of a basic skincare regimen : P54
Chronic urticaria: guidelines, diagnosis and management : P55
Smoking and scarring severity in acne : P56
Mycobacterium chelonae outbreak following tattoo shading : P57
A decade later, has the prevalence of skin colonization by resistant propionibacteria increased in our patients with acne? : P58
Outpatient discharge decision taking: patients' perspectives challenge current practice : P59
Longevity of biological drug effect in patients with psoriasis: results from a retrospective U.K. study : P60
Psoriasis Area and Severity Index correlates with circulating levels of insulin, irrespective of body mass index or waist circumference : P61
An observational study to investigate health-seeking behaviour in patients with psoriasis using framework analysis : P62
The utility of patient ‘selfies' to aid dermatological diagnoses : P63
The implications of underlying anxiety and depression in patients with psoriasis: understanding the patterns of biological therapy use and treatment outcomes during standard U.K. clinical care (PICTURE study) : P64
Four cases of unusual marginal alopecia presenting to two tertiary hair clinics : P65
Hailey-Hailey disease linked to bipolar affective disorder : P66
Toxic epidermal necrolysis secondary to deferasirox confirmed by in vitro drug hypersensitivity testing : P67
Retrospective case-note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in U.K. secondary care : P68
Elastodystrophic naevus: a newly described entity : P69
Isolation of Mycobacterium iranicum , a novel species, from the cutaneous lesions of a patient in the U.K. : P70
Twenty years on APSEA still hits the spot: validation of the Assessment of the Psychological and Social Effects of Acne (APSEA) questionnaire in a large cohort of patients with acne : P71
‘Stroking’ the surface: unilateral psoriasis following a cerebral vascular accident : P72
Insulin resistance and the metabolic syndrome in hidradenitis suppurativa : P73
Legal claims in Scottish National Health Service dermatology departments 2002-13 : P74
Additional diagnoses in the rapid-access clinic: the benefits of full-skin examination : P75
Erythroderma of uncertain origin: an age-related phenomenon? : P76
Attitudes towards sun exposure in patients with inflammatory bowel disease taking azathioprine : P77
What is the relationship between acne and smoking? : P78
The ‘mole men’: the doctors who have shaped our diagnosis of melanocytic lesions : P79
Residual melanoma in wide local excision specimens : P80 (PP5)
Network analysis identifies master regulators of metastasis in cutaneous melanoma : P81
Is an online skin cancer toolkit an effective way to educate primary care physicians about skin cancer diagnosis and referral? : P82 (PP9)
Evaluation of malignancies in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) : P83
Skin toxicity and oedema in metastatic melanoma treated with mitogen-activated protein kinase kinase inhibitors : P84
Dermoscopy of amelanotic nodules : P85
Merkel cell carcinoma: rising incidence in the U.K. : P86
Comparison of pathways to diagnosis of nodular melanoma and superficial spreading melanoma : P87
Retrospective study of vulval basal cell carcinoma : P88
Management of squamous cell carcinoma: our experience : P89
The incidence, clinical features and prognosis of cutaneous metastatic disease in patients with solid malignant tumours : P90
Palliative radiotherapy for Merkel cell carcinoma: single-centre experience and review of the literature : P91
A comparative study examining the management of squamous cell carcinoma in situ (Bowen disease) in the U.K. and Australia : P92
Adapalene/benzoyl peroxide fixed-dose combination for the prevention and treatment of atrophic acne scars : P93 (PP2)
Modelled analysis of serious infection risk in the treatment of psoriasis with biologics and systemic treatments in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) : P94
Fumaric acid esters for psoriasis: Cochrane systematic review : P95
Immune responses in contact immunotherapy with diphenylcyclopropenone : P96 (PP3)
Interim analysis of dipeptidyl peptidase-4 inhibition and narrowband ultraviolet B light in psoriasis (DINUP): a randomized controlled trial : P97 (PP4)
Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey : P98
Adapalene 0.3%/benzoyl peroxide 2.5% topical gel: efficacy and safety in moderate and severe acne vulgaris : P99
Apremilast demonstrates consistent efficacy across Dermatology Life Quality Index subgroups: an analysis of clinical trial data : P100
Weekly azathioprine pulse vs. methotrexate for the treatment of chronic plaque psoriasis : P101
Successful treatment of pyoderma gangrenosum with the interleukin-1 receptor antagonist anakinra: a case series of three patients : P102 (PP12)
White light-emitting diode topical methyl 5- aminolaevulinate photodynamic therapy: a novel treatment option that is as effective and well tolerated as daylight photodynamic therapy for the treatment of actinic keratoses : P103
Split-face placebo-controlled study to evaluate the efficacy of type A botulinum toxin in postacne facial scars : P104
Management of hidradenitis suppurativa: a U.K. survey of current practice : P105
Comparison of the efficacy and safety profiles of topical bimatoprost 0.03% in combination with narrowband ultraviolet B (NB-UVB) vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial : P106
Quantifying radiant exposure of daylight and white light-emitting diode (LED) light used to treat patients with actinic keratoses with topical methyl 5-aminolaevulinic acid photodynamic therapy (PDT), and comparison with two conventional red-light LED PDT sources : P107
Dermatology Quality Life Index (DLQI) responses to biological therapy for psoriasis during standard U.K. clinical care: NICE assessment timelines may not capture the best DLQI response (PICTURE study) : P108
Retrospective review of the efficacy of psoralen-ultraviolet A and narrowband ultraviolet B in the management of generalized granuloma annulare : P109
Does spironolactone have a place in the treatment of acne in female patients? : P110
Itolizumab, a unique upstream immunomodulator in the treatment of psoriasis: in-clinic experience : P111
Identifying key components for a psychological intervention for people with vitiligo : P112
Trends in antibiotic resistance patterns of Staphylococcus aureus isolates from dermatology patients in the U.K. over 12 years : P113
Clinicopathological study of epidermal growth factor receptor inhibitor-induced papulopustular lesions : P114
Naltrexone: a novel treatment for Hailey-Hailey disease : P115
Assessment of a visual risk communication aid used to support patients in deciding about biological therapy : P116
Prospective study of the use of daylight photodynamic therapy for the treatment of actinic keratoses in Ireland : P117
Association of topical psoriasis treatment with subsequent disease worsening or secondary care referral: analysis of a U.K. general practice database : P118
Monitoring patients with hidradenitis suppurativa on rifampicin and clindamycin combination therapy : P119
Caution with botulinum toxin A in the treatment of hyperhidrosis in a patient with congenital myasthenic syndrome : P120
Xeroderma pigmentosum: increasing awareness of the variation in presenting clinical features in order to avoid diagnostic delay and improve prognosis : BG01
Clinical heterogeneity in autosomal recessive congenital ichthyosis due to NIPAL4 /ichthyin mutations : BG02
Co-occurrence of NRAS and BRAF activating mutations in congenital melanocytic naevi : BG03
A novel peeling skin syndrome : BG04
Mutations in desmoglein 1 causing clinically heterogeneous inherited palmoplantar keratoderma : BG05
Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES): development of an electronic data capture tool in recessive dystrophic epidermolysis bullosa : BG06
Characterization and selection of a patient cohort for a phase I/II study of ex vivo gene therapy for recessive dystrophic epidermolysis bullosa (GENEGRAFT) : BG07
Farber disease: an unusual case in a dermatology clinic : BG08
Two cases of patients with Ehlers-Danlos syndrome type VIII and hoarseness : BG09
Chromosome 3 partial triplication in association with pigmentary mosaicism : BG10
Two cases of rare variants of dystrophic epidermolysis bullosa with late onset of symptoms : BG11
A second family with a telomerase reverse transcriptase ( TERT ) promoter gene mutation associated with melanomas : BG12
Full-thickness skin grafting for pseudoainhum in loricrin palmoplantar keratoderma : BG13
Neurofibromatosis type I or Legius syndrome? An emerging diagnostic challenge : BG14
Deafness and a recurrent erythrokeratoderma-like rash with marked perineal involvement, due to a heterozygous mutation in GJB2 (connexin 26, F142L) : BG15
New missense mutation in type VII collagen in an adult with autosomal recessive pretibial epidermolysis bullosa : BG16
Linear skin defects and microphthalmia: a case report : BG17
Cystic fibrosis carrier status presenting with aquagenic palmar wrinkling : BG18
5% Imiquimod (Aldara) clears lentigines in patients with xeroderma pigmentosum : BC01
Mesotherapy with botulinum toxin: the only answer for open nasal pores : BC02
What is the relationship between body mass index and acne? : BC03
Delayed granulomatous reaction to dermal filler : BC04
Platelet-rich plasma induces selective improvement in androgenetic alopecia but not in alopecia areata : BC05
An unexpected side-effect of topical 5-fluorouracil : BC06
Granulomatous reaction to eyebrow tattooing responding to potent topical steroid treatment : BC07
Paediatric solar urticaria: a case series : PD01
Solar urticaria: an examination of the action spectra in 125 patients : PD02
The use of omalizumab in three patients with solar urticaria : PD03
Solar urticaria occurring in two patients with erythropoietic protoporphyria: a pointer to an endothelial antigen in solar urticaria? : PD04
Retrospective review of the efficacy of psoralen-ultraviolet A and narrowband ultraviolet B in the management of generalized granuloma annulare : PD05
White light-emitting diode topical methyl 5-aminolaevulinate photodynamic therapy: a novel treatment option that is as effective and well tolerated as daylight photodynamic therapy for the treatment of actinic keratoses : PD06
High cumulative doses of narrowband ultraviolet B (NB-UVB) in vitiligo: none of a group of 48 patients receiving over 100 NB-UVB treatments developed skin cancer in the medium term : PD07
Variegate porphyria in a child with developmental delay : PD08
Do photosensitizing drugs pose a significant risk of adverse reaction to TL01 ultraviolet B? : PD09
Retrospective study to assess the effect of skin cooling on the outcome of photodynamic therapy for Bowen disease and superficial basal cell carcinoma : PD10
Late diagnosis of xeroderma pigmentosum variant in an elderly patient with skin type V : PD11
PD12
Out of the frying pan and into the fire : PD13
A case of recalcitrant solar urticaria successfully treated with omalizumab : PD14
Know your enemy: lessons from three-dimensional virtual reconstruction of benign skin tumours : DS01
Mohs micrographic surgery utilizing fluorescence confocal microscopy: a pilot study of 12 patients : DS02
The ‘triangle’ sign - an important dermoscopic feature of early invasive nail unit melanoma : DS03
Mohs micrographic surgery educational video: a randomized controlled study : DS04
‘Location, location, location’ during Mohs surgery consultations: does it make a difference? A randomized, controlled trial : DS05
Comparative data analysis of dermatological surgeons within a Mohs unit : DS06
Surgical management of dermatofibrosarcoma protuberans: a 10-year review of clinical practice in the U.K. : DS07
Platelet rich plasma: a novel therapeutic perspective for female pattern alopecia : DS08
Periocular reconstruction: highlighting the versatility of the rotating V to Y advancement flap : DS09
Mohs micrographic surgery for squamous cell carcinoma: is it used enough? A survey of U.K. practitioners and reflections on 249 cases treated at a tertiary referral centre : DS10
Mohs micrographic surgery in the treatment of porocarcinoma : DS11
Advancing Bernard, Burow and Webster in perioral reconstruction : DS12
Novel transposed island pedicle flap for repair of lateral nasal alar defects: a series of three cases : DS13
The RAST flap in posterior auricular reconstruction : DS14
A modified ‘shark’ flap for repair of perialar defects : DS15
Advancements and ‘intraoperative zigzags’ for superior results in nasal tip repair : DS16
Laser hair removal for recurrent pilonidal sinus disease. Does it really work? : DS17
The Mohs micrographic surgery database: a 6-year experience with periocular tumours : DS18
Outcome of ocular Mohs surgery: primary repair versus secondary intention healing : DS19
Treatment of periocular actinic keratosis with topical 5% 5-fluorouracil: a retrospective observational study between 2007 and 2014 in a combined clinic in a single centre : DS20
Recombinant protease for cell separation as a safer alternate to trypsin in noncultured epidermal suspension transplantation in stable vitiligo : DS21
Should additional preoperative precautions and monitoring be performed for skin surgery in patients who have a cardiac rhythm device? : DS22
Use of cryogesic spray and cryotherapy for administration of plantar injections of botulinum toxin in epidermolysis bullosa hyperhidrosis : DS23
Approaches to reconstructing the ‘goat’ of the ear : DS24
A novel, hinged banner transposition flap for reconstruction of the entire earlobe : DS25
Minimizing ectropion and avoiding Mustardé: trilobe flap reconstruction for large defects of the nasojugal fold : DS26
Feasibility of a clinical trial investigating surgical management of dermatofibrosarcoma protuberans in the U.K. : DS27
Development of a Mohs surgery histopathology database : DS28
Sebaceous carcinoma treated by Mohs micrographic surgery: a review of 14 cases : DS29
The benefit of full-skin examination by dermatologists as a part of strategy to diagnose melanoma early : DS30
Our experience with the intralesional liquefaction technique to treat large lipomas : DS31
Mohs micrographic surgery for the treatment of superficial angiomyxoma : DS32
Clean enough? Exploring the aseptic behaviours amongst U.K. dermatological surgeons : DS33
Score and shave technique for freehand scalpel harvesting split thickness skin grafts: utility in auricular reconstruction : DS34
Training of advanced skin surgeons: are we making full use of the technology available to us? : DS35
Clinical and pathological features of pure and mixed desmoplastic melanomas : DS36
Who should teach skin suturing? : DS37
Skin surgery: ‘a patient's perspective’ : DS38
Dermoscopic features of rare tumours : DS39
Patient satisfaction of bilobe flap, trilobe flap and island pedicle flap reconstruction of nasal defects after Mohs micrographic surgery : DS40
‘Trimming a ring at the edge of neoplastic cutaneous head lesions’ (TRENCH) for excision of large tumours: a modified variant of Mohs surgery : DS41
Reconstructing a challenging defect of the antihelix and scapha of the ear: think about rolling over before Antia and Buch : DS42
Extranasal application of an interpolated paramedian forehead flap : DS43
A successful audit: the improved management of squamous cell carcinoma in a U.K. district general hospital : DS44
A simple algorithm for assessment of local anaesthetic allergy in cutaneous surgery? : DS45
Polarized vs. nondepolarized dermoscopy for common skin lesions : DS46
Chemo-wrapping with topical 5-fluorouracil for treatment of challenging Bowen disease: report of two cases : DS47
Use of prophylactic antibiotics in patients undergoing skin surgery : DS48
Cetuximab for the management of metastatic cutaneous squamous cell carcinoma in a renal transplant recipient : DS49
Methotrexate in the management of keloid scars: a novel approach : DS50
Sebaceous carcinoma: the great masquerader : DS51
Incidence of residual tumour in incompletely excised nonmelanocytic malignant skin lesions: an audit cycle completed : DS52
Incompletely excised superficial angiomyxoma of the scalp treated by Mohs micrographic surgery : DS53
Periauricular and nuchal epidermal naevi successfully treated with carbon dioxide laser : DS54
Mohs micrographic surgery: a needs assessment of patients with basal cell carcinoma attending a large U.K. health care trust : DS55
Dural invasion of scalp squamous cell carcinoma in a cardiac transplant patient : DS56
Crossing bridges in nasal reconstruction with V to Y advancement flaps: challenging the hallowed dogma of cosmetic subunit repair : DS57
A unilateral advancement flap for upper eyelid reconstruction: an elegant yet unreported reconstructive option : DS58
Dermatology surgical nurse practitioners: ‘putting in the graft’ to improve efficiency during Mohs micrographic surgery : DS59
Audit of malignant melanoma and cutaneous squamous cell carcinoma managed on the treatment pathway for basal cell carcinoma in a regional cancer network : DS60
Conservative management of a traumatic superficial temporal artery aneurysm : DS61
Plastic surgery-radiotherapy-dermatology joint clinic: patient satisfaction with a multidisciplinary approach in skin cancer management in a tertiary centre and the impact on waiting times for treatment : DS62
Pigmented lesions: experience matters : DS63
Three point-advancement closure : DS64
Periocular skin surgery: investigating case mix and outcomes across specialties at a regional teaching hospital : DS65
Metastatic papillary thyroid carcinoma in a patient with multiple eruptive squamous cell carcinomas : DS66
An inherited BAP1 mutation in a U.K. family : DP01
Novel insights into skin tumour development in Birt-Hogg-Dubé syndrome using three-dimensional virtual tumour reconstruction : DP02
Squamoid eccrine ductal carcinoma: a clinicopathological study of 30 cases : DP03
The relationship between CD30+ intravascular T-cell lymphoproliferations and reactive processes : DP04
Three cases of paraneoplastic lupus associated with carcinoma of the colon, lung and breast : DP05
A clinicopathological and prognostic review of spitzoid tumour of uncertain malignant potential: a retrospective study of cases in a U.K. tertiary referral centre : DP06
Granulomatous mycosis fungoides and slack skin: one disease, different phenotypes : DP07
Giant keratoacanthoma in young patients: when the sun is not to blame : DP08
A rare presentation of cutaneous sarcoidosis : DP09
Mycosis fungoides presenting as naevoid hyperkeratosis of the areola and unilateral acanthosis nigricans : DP10
Interstitial granulomatous dermatitis variant of scleromyxoedema : DP11
Eruptive poromatosis secondary to radiotherapy: an unusual case : DP12
IgG4-related skin disease : DP13
Rosai-Dorfman disease manifesting with panniculitis in a white man : DP14
An unusual pruritic variant of a common condition : DP15
A rare case of reactive angioendotheliomatosis secondary to cryoglobulinaemia : DP16
‘Doctor, I have to wear a scarf’: an unusual cause of skin changes at the neck : DP17
Auricular squamous cell carcinoma: a tertiary referral centre experience : DP18
Cutaneous vasculitis responding to dapsone in a man with alpha-1-antitrypsin deficiency : DP19
Spontaneous regression of metastatic cutaneous melanoma : DP20
Spectrum of predisposing factors and histopathological subtypes of cutaneous squamous cell carcinoma at a tertiary centre : DP21
Adolescent saxophone penis secondary to Crohn disease, misdiagnosed as being post-traumatic : DP22
Primary dermal melanoma: a rare but important presentation : DP23
Case report: a new presentation of systemic lupus erythematosus manifesting as Rowell syndrome with lupus nephritis : DP24
Syringotropic melanoma: report of two cases of a rare variant of malignant melanoma involving the eccrine apparatus : DP25
The role of skin biopsy in suspected graft-versus-host disease : BI01
X-linked lymphoproliferative syndrome-1 complicated by a drug hypersensitivity syndrome and graft-versus-host disease : BI02
Cutaneous Mycobacterium chelonae infections in immunocompromised patients following solid organ transplants : BI03
Isolation of Mycobacterium iranicum , a novel species, from the cutaneous lesions of a patient in the U.K. : BI04
Herpes simplex virus in the immunocompromised: a master of disguise : BI05
Two diverse skin complications of common variable immunodeficiency : BI06
A clinicopathological study of melanoma associated with chronic lymphocytic leukaemia : BI07
Primary cutaneous T-cell lymphoma posttransplant: an unknown quantity : BI08
Attitudes to ultraviolet exposure in patients with inflammatory bowel disease : BI09
Aciclovir-resistant herpes simplex virus in a cohort of allogeneic haematopoietic stem cell recipients : BI10
Microbiology and skin care management of Kaposi sarcoma-associated lymphoedema : BI11
Developing a dedicated dermatology service for allogeneic bone marrow transplant recipients : BI12
Primary cutaneous Cryptococcus infection in a renal transplant recipient : BI13
Primary cutaneous nocardiosis with central nervous system dissemination in a patient with acute promyelocytic leukaemia after allogeneic stem cell transplantation : BI14
Auricular beading: a distinctive pattern of leukaemia cutis : BI15
Distal extremities swelling associated with TRUVADA® : BI16
Ibrutinib-induced acute generalized exanthematous pustulosis : BI17
Inflammation of actinic keratoses during paclitaxel chemotherapy : BI18
A case of eosinophilic dermatosis of haematological malignancy in an immunocompromised patient : BI19
An unusual cause of leg ulcer : BI20
A malignancy while on biologics in the treatment of psoriasis: a case series : BI21
Case report: calciphylaxis in a patient on long-term corticosteroid immunosuppression : BI22
Changing skin cancer risk postrenal transplantation? : BI23
Histology-negative Mycobacterium chelonae infection: a disguise : BI24
Drug reaction with eosinophilia and systemic symptoms syndrome following ipilimumab for metastatic melanoma : BI25
A retrospective analysis of nonmelanoma skin cancer in a renal transplant population : BI26
Palmoplantar pustulosis secondary to rituximab : BI27
‘The physician who knows syphilis knows medicine’: secondary syphilis masquerading as pityriasis rosea : BI28
Dermatological manifestations of syphilis : BI29
The case of the masquerading Kaposi sarcoma: a diagnostic and therapeutic challenge : BI30
Chronic bullous dermatosis of childhood in a liver transplant recipient: a causative relationship? : BI31
Basal cell carcinoma of the left arm in an 18-year-old woman : BI32
Oral leucoplakia as a manifestation of graft-versus-host disease : BI33
A 5-year single-centre review of children with segmental haemangioma of the head and neck : PA01
Real-life experiences of managing childhood psoriasis: a U.K. multicentre audit of the assessment and management of psoriasis in children : PA02
A pilot, assessor-blinded, randomized controlled trial of topical oils for neonatal skin : PA03
Training needs in young adult and adolescent health and transitional medicine among dermatology higher specialist trainees in the U.K. : PA04
Management of naevus sebaceus: a national survey of U.K. dermatologists : PA05
A case of chilblains associated with interleukin-1 receptor-associated kinase-4 deficiency : PA06
The use of phototherapy in a paediatric population : PA07
Mutations in EXPH5 (exophilin-5) underlie a rare subtype of autosomal recessive epidermolysis bullosa simplex : PA08
Thymus hypoplasia in generalized severe junctional epidermolysis bullosa : PA09
A case of insensitivity to pain: hereditary sensory and autonomic neuropathy : PA10
Could early detection of juvenile psoriatic arthritis be improved by better recognition of how psoriasis presents in children? Structured interviews with 10 U.K. paediatric rheumatology centres : PA11
Atypical cutaneous abscesses in an immunocompromised infant : PA12
Modelling optimal clinical pathways in secondary care paediatric atopic eczema : PA13
Rapp-Hodgkin syndrome due to de novo mutation in TP63 : PA14
Paediatric presentations of Panton-Valentine leucocidin (PVL) Staphylococcus aureus : PA15
Fragile hair in a child: don't forget argininosuccinic aciduria : PA16
Xanthoma disseminatum: to treat or not to treat? : PA17
An extremely rare case of ablepharon-macrostomia syndrome : PA18
Idiopathic infantile pyoderma gangrenosum: our experience : PA19
Leishmaniasis recidivans in a child: a treatment challenge : PA20
A cluster of disseminated tinea infection in a rural family including a 4-week-old infant : PA21
A case of pyoderma gangrenosum in a 1-year-old child associated with pathergy : PA22
An unusual case of recalcitrant facial eczema in a child : PA23
Idiopathic vulval calcinosis in a child : PA24
A case of van der Woude syndrome : PA25
Eczema school : PA26
Hyper-IgE syndrome masquerading as neonatal cephalic pustulosis : PA27
Atypical hand, foot and mouth disease due to Coxsackie virus type A6, an experience from Newcastle in 2014 : PA28
A family with autosomal dominant sensorineural hearing loss and cicatrizing keratoderma (Vohwinkel syndrome) : PA29
Temporal triangular alopecia: a series of three cases : PA30
A case of a fibroblastic connective tissue naevus: an unusual clinical presentation : PA31
Langerhans cell histiocytosis: a mimic of scabies in children : PA32
An audit to assess the management of paediatric dermatology patients taking immunosuppressants : PA33
Segmental pigmentary anomaly and ataxia telangiectasia : PA34
Sniffing out a diagnostic dilemma: TB or not TB? : PA35
What are the optimal concentrations of oxidized limonene and linalool for patch testing? : CD01
Nail varnish allergens, one step forward, two steps back? : CD02
Two unusual cases of type IV hypersensitivity to 2-hydroxyethyl methacrylate : CD03
Four cases of allergic contact dermatitis to methylisothiazolinone in ironing water : CD04
Allergic contact dermatitis to acrylates in consumers : CD05
A curious case of contact allergy to Acid Red 33: when allergy to fragrance is not a fragrance allergy : CD06
The frequency of coassociated allergy of octylisothiazolinone and benzisothiazolinone with methylisothiazolinone : CD07
Patch testing in patients with psoriasis: results of a 30-year retrospective cohort study : CD08
Contact allergy to essential oils cannot always be predicted from allergy to fragrance markers in the standard battery, in patients with a history of reacting to cosmetics : CD09
Personal protective equipment-associated dermatoses reported to EPIDERM: a 20-year review : CD10
Methylisothiazolinone as a preservative in cosmetics and toiletries: are the public still at risk? : CD11
Salicylates: the incidence and relevance of positive patch tests : CD12
Has the methylisothiazolinone epidemic reached its peak? : CD13
The new face of garlic allergy? : CD14
Anaphylaxis to alginate dressing : CD15
Patch test preparation and application audit : CD16
Benzisothiazolinone is not a common allergen in a general patch test population, and 2-n-octyl-4-isothiazolin-3-one, despite being positive in a noticeable proportion of subjects with hand dermatitis, is of uncertain relevance : CD17
Contact allergy to methylchloroisothiazolinone and methylisothiazolinone: an update : CD18
Anogenital itch triggered by allergic contact dermatitis to methylchloroisothiazolinone, methylisothiazolinone and topical clotrimazole with subsequent generalized exanthema triggered by oral fluconazole : CD19
Glove-related hand urticaria: an increasing occupational problem among healthcare workers : CD20
Contact allergy resulting from occupational exposure to olein and oleic acid : CD21
An erythema multiforme-pattern contact dermatitis to windscreen resin : CD22
The role of patch testing in patients with perianal dermatoses and pruritus ani : CD23
To do or not to do 20 min of patch testing in oral disease : CD24
An update of contact allergy to methylisothiazolinone and sources of exposure : CD25
A follow-up study of vaccine-induced aluminium contact allergy in a population of 76 000 children vaccinated with aluminium-adsorbed vaccine: differences in patch test reaction between aluminium hexahydrate 2% in petrolatum and metallic aluminium : CD26
Teledermatology: an audit of patient and referring physician satisfaction : BTS01
Primary teledermatology: as efficient as secondary teledermatology : BTS02
Experience of using Choose and Book Advice and Guidance teledermatology for skin lesions in a district general hospital : BTS03
Diagnostic accuracy of a store-and-forward teledermoscopy clinic for skin cancer referrals : BTS04
The use of mobile devices by medical staff to image patients in a district general hospital setting : BTS05
The arsenic story and Edinburgh : H01
Breaking the glass ceiling: Agnes Blackadder, Britain's first female dermatologist : H02
The history of alopecia areata : H03
Wound care from antiquity to the present day: an illustrated review : H04
The resurgence of Cimex lectularius : a slumberous fiend : H05
A review of the skin diseases from the trenches of the Great War : H06
Trench foot: from the Grande Armée to Glastonbury : H07
Raymond Sabouraud (1864-1938): looking through the hyphae : H08
A history of cryotherapy in dermatology: the cold cure : H09
Arnault Tzanck (1886-1954): a great dermatologist who revolutionized the field of blood transfusion : H10
Darrell Wilkinson (1919-2009): a giant of dermatology : H11
A man ahead of his time: Moritz Kaposi : H12
Arthur Whitfield (1868-1947) MD FRCP: the ointment of kings : H13
Hulusi Behçet: a Turkish gem : H14
Human attitudes to sun exposure and the history of sun protection : H15
Multiple synonyms and misguided therapies: a history of lichen sclerosus : H16
A north-west pioneer dermatologist : H17
Chronic urticaria: the story of autoimmunity : H18
Stress, emotion and acne: a historical view : H19
Dermatological content of U.K. undergraduate curricula: where are we now? : DT01
Cloud formation: multiple web tools to enhance webinar-based learning : DT02
Back to the future: the development of an undergraduate dermatology programme : DT03
Increasing exposure to dermatology during core medical training: an innovative programme at St George's Hospital, London : DT04
Survey of patients' attitudes towards medical students in a busy outpatient dermatology department : DT05
Dermatology teaching at undergraduate and postgraduate level: has it improved? : DT06
A new induction course for dermatology registrars evaluating learning needs for new trainees : DT07
Palmar and flexural hypertrophic lupus erythematosus: an extremely rare variant of discoid lupus erythematosus : INT01
A day in a Sudanese dermatology clinic : INT02
A 5-year retrospective analysis of scabies diagnosis and management in general practices in Hackney : INT03
The development and implementation of stepped-care psychological support in medical dermatology : PS01
Managing patients with delusional infestations in psychodermatology clinics is much more cost-efficient than general dermatology or primary care clinics : PS02
Integrated mental health assessment in a tertiary medical dermatology service: feasibility and the prevalence of common mental disorder : PS03
Cost-effectiveness in psychodermatology: a case series : PS04
Assessing psychological need in dermatology patients: the importance of cross-methodology : PS05
Habit reversal for refractory atopic dermatitis : PS06
Acne excoriée: improved outcomes with low-dose isotretinoin in an integrated multidisciplinary team care setting : PS07
Identifying key components for a psychological intervention for people with vitiligo : PS08
Illness perception in association with psychological functioning in patients with discoid lupus erythematosus : PS09
Illness perception in individuals with hidradenitis suppurativa at a tertiary referral clinic : PS10
Histological findings in dermatitis artefacta: clinicopathological correlation of skin biopsies is essential to avoid unnecessary treatments or to exclude organic disease : PS11
Retrospective descriptive study of patients with psoriasis referred to a psychology-based psychodermatology service : PS12
Use of a preconsultation questionnaire to break the ICE : PS13
Melanoma mind-map: from mole to metastasis : PS14
Psychosocial well-being and quality of life in rosacea: a systematic literature review : PS15
Quality of life in Irish female patients with lichen sclerosus : PS16
Cutaneous self-inflicted injury in the context of mental health disorder : PS17
‘It's a traumatic illness, traumatic to witness.’ A qualitative study of the experiences of bereaved carers of patients with cutaneous T-cell lymphoma : PS18
PS19
A unifying psychodermatological diagnosis in two sisters : PS20
Primary seborrhoea treated with oral isotretinoin: effective but hard to stop : PS21